These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 3852778)

  • 21. Stimulation of the intracellular killing of Staphylococcus aureus by monocytes: regulation by immunoglobulin G and complement components C3/C3b and B/Bb.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    J Immunol; 1982 Jul; 129(1):332-7. PubMed ID: 6979568
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evasion of alternative complement pathway by Trypanosoma cruzi results from inefficient binding of factor B.
    Joiner K; Sher A; Gaither T; Hammer C
    Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6593-7. PubMed ID: 2944112
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Alterations in C3 activation and binding caused by phosphorylation by a casein kinase released from activated human platelets.
    Ekdahl KN; Nilsson B
    J Immunol; 1999 Jun; 162(12):7426-33. PubMed ID: 10358196
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased serum C3 levels in Crry transgenic mice partially abrogates its complement inhibitory effects.
    Kang HJ; Bao L; Xu Y; Quigg RJ; Giclas PC; Holers VM
    Clin Exp Immunol; 2004 May; 136(2):194-9. PubMed ID: 15086380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Experimental confirmation of the C3 tickover hypothesis by studies with an Ab (S77) that inhibits tickover in whole serum.
    Lachmann PJ; Lay E; Seilly DJ
    FASEB J; 2018 Jan; 32(1):123-129. PubMed ID: 28855277
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
    Kazatchkine MD; Fearon DT; Austen KF
    J Immunol; 1979 Jan; 122(1):75-81. PubMed ID: 762425
    [No Abstract]   [Full Text] [Related]  

  • 27. Interaction of C3b, B, and D in the alternative pathway of complement activation.
    Nicholson A; Brade V; Schorlemmer HU; Burger R; Bitter-Suermann D; Hadding U
    J Immunol; 1975 Oct; 115(4):1108-13. PubMed ID: 240884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification and characterization of a human membrane protein that activates the alternative complement pathway and allows the deposition of homologous complement C3.
    Matsumoto M; Yamashita F; Iida K; Tomita M; Seya T
    J Exp Med; 1995 Jan; 181(1):115-25. PubMed ID: 7806998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Deficiency of the Complement Component 3 but Not Factor B Aggravates Staphylococcus aureus Septic Arthritis in Mice.
    Na M; Jarneborn A; Ali A; Welin A; Magnusson M; Stokowska A; Pekna M; Jin T
    Infect Immun; 2016 Apr; 84(4):930-939. PubMed ID: 26787717
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lessons from functional and structural analyses of disease-associated genetic variants in the complement alternative pathway.
    Rodríguez de Córdoba S; Harris CL; Morgan BP; Llorca O
    Biochim Biophys Acta; 2011 Jan; 1812(1):12-22. PubMed ID: 20837143
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
    Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
    J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation of complement fragments C3b and C3a from purified rat complement component C3 by activated cobra venom factor.
    Usami M; Ohno Y
    J Pharmacol Toxicol Methods; 2005; 52(2):260-3. PubMed ID: 16125624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cleavage of C3 by a neutral cysteine proteinase of Entamoeba histolytica.
    Reed SL; Keene WE; McKerrow JH; Gigli I
    J Immunol; 1989 Jul; 143(1):189-95. PubMed ID: 2543700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in Cryptococcus neoformans capsular polysaccharide structure influence assembly of alternative complement pathway C3 convertase on fungal surfaces.
    Washburn RG; Bryant-Varela BJ; Julian NC; Bennett JE
    Mol Immunol; 1991; 28(4-5):465-70. PubMed ID: 2062324
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of the C3b binding site in a recombinant vWF-A domain of complement factor B by surface-enhanced laser desorption-ionisation affinity mass spectrometry and homology modelling: implications for the activity of factor B.
    Hinshelwood J; Spencer DI; Edwards YJ; Perkins SJ
    J Mol Biol; 1999 Nov; 294(2):587-99. PubMed ID: 10610782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of gangliosides on activation of the alternative pathway of human complement.
    Michalek MT; Bremer EG; Mold C
    J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3.
    Luo S; Hartmann A; Dahse HM; Skerka C; Zipfel PF
    J Immunol; 2010 Aug; 185(4):2164-73. PubMed ID: 20644161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding sites involved in the formation of the C3 (H2O)-factor B complex of the alternative pathway of complement.
    Williams SC; Sim RB
    Biochem Soc Trans; 1994 Feb; 22(1):2S. PubMed ID: 8206227
    [No Abstract]   [Full Text] [Related]  

  • 39. A molecular basis of activation of the alternative pathway of human complement.
    Austen KF; Fearon DT
    Adv Exp Med Biol; 1979; 120B():3-17. PubMed ID: 390986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the alternative pathway of human complement by the extracellular slime glycolipoprotein of Pseudomonas aeruginosa.
    Lambris J; Papamichail M; Ioannidis C; Dimitracopoulos G
    J Infect Dis; 1982 Jan; 145(1):78-82. PubMed ID: 6798132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.